ClinicalTrials.Veeva

Menu

Prospective Stratification of Infectious Risks in Multiple Sclerosis (InRIMS)

University Hospital Basel logo

University Hospital Basel

Status

Active, not recruiting

Conditions

Multiple Sclerosis

Treatments

Other: MS-adapted AWIS questionnaire (MS-AWIS)
Other: infection diary (MS-AWIS diary)

Study type

Observational

Funder types

Other

Identifiers

NCT04036097
2019-00465 me18Decard;

Details and patient eligibility

About

This monocentric study is to identify factors that increase the susceptibility for infections and establish a questionnaire-based infection score that allows a prospective stratification for infectious risks in patients with multiple sclerosis (MS) (InRIMS-Study). The study will utilize a validated, MS-adapted questionnaire and infection diary from the Airway Infection Susceptibility (AWIS) study in a regularly followed, prospective cohort of MS patients. It is a nested project of the prospective observational Swiss MS Cohort (SMSC) and SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation) studies.

Enrollment

254 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signed informed consent form (ICF) for the InRIMS-study and Swiss MS Cohort (SMSC) and/or Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT) study

Exclusion criteria

  • Not able to sufficiently understand the patient information and questionnaire (German language)
  • MS Patients with long-term antibiotic prophylaxis
  • MS Patients with known primary immunodeficiency, under chemotherapy due to any malignancy or HIV infection.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems